T1	Treatment 167 175	imipenem
T2	Treatment 180 189	meropenem
T3	Treatment 283 377	constant 30-min infusion of either 1 g of imipenem plus 1 g of cilastatin or 1 g of meropenem.
T4	Treatment 434 497	determined by bioassay and high-pressure liquid chromatography.
T5	Treatment 547 602	two-compartment model and a noncompartmental technique.
